Medindia
Medindia LOGIN REGISTER
Advertisement

By 2018, AVEO Pharmaceuticals' Tivozanib Will Garner Sales of Up To $100 Million in the Renal Cell Carcinoma Drug Market

Thursday, February 4, 2010 General News
Advertisement
Tivozanib Is Expected to Launch in 2013 in the United States and Europe, According to Findings from Decision Resources

For more information, contact:

Decision Resources

Decision Resources, Inc.

Gisselle Morales

Christopher Comfort

781-296-2691

781-296-2597

[email protected]

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close